Metraipolis › archive › dc_2ffee55dc3c8

Metabolic reprogramming and immunosenescence: a new sight for glioma therapy — Europe PMC PMID:41684840

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41684840
DOI: 10.3389/fcell.2026.1754980
License (as archived): solo-consultazione
Archived: 2026-11-06T11:39:49.234Z
SHA-256 of the archived text: 3f1f6d9d2a541049c601465fe8a9c4a02c8d00d8b26a1f091a6898acb292c557
Stable URL of this page: https://metraipolis.com/documento/dc_2ffee55dc3c8

How to cite

Metabolic reprogramming and immunosenescence: a new sight for glioma therapy — Europe PMC PMID:41684840 — Europe PMC (en), https://europepmc.org/article/MED/41684840 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2ffee55dc3c8 (Metraipolis archive dc_2ffee55dc3c8, sha256 3f1f6d9d2a541049c601465fe8a9c4a02c8d00d8b26a1f091a6898acb292c557)

BibTeX

@misc{dc2ffee55dc3c8,
  title = {Metabolic reprogramming and immunosenescence: a new sight for glioma therapy — Europe PMC PMID:41684840},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41684840},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2ffee55dc3c8; sha256 3f1f6d9d2a541049c601465fe8a9c4a02c8d00d8b26a1f091a6898acb292c557},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41684840. Agents can read the archived copy with the MCP tool read_document.